Quarterly Journal of Nuclear Medicine and Molecular Imaging This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Pediatric nuclear medicine: continuing the evolution
Q J Nucl Med Mol Imaging. 2024 Mar;68(1):1-2. doi: 10.23736/S1824-4785.24.03562-3.NO ABSTRACTPMID:38587359 | DOI:10.23736/S1824-4785.24.03562-3 (Source: Quarterly Journal of Nuclear Medicine and Molecular Imaging)
Source: Quarterly Journal of Nuclear Medicine and Molecular Imaging - April 8, 2024 Category: Nuclear Medicine Authors: Pinar Ozgen Kiratli Pietro Zucchetta Source Type: research

Gastrointestinal radionuclide imaging in pediatric age group
Q J Nucl Med Mol Imaging. 2024 Mar;68(1):23-31. doi: 10.23736/S1824-4785.24.03548-9.ABSTRACTPediatric gastrointestinal imaging plays a crucial role in evaluating and managing digestive system disorders in children. This comprehensive review dives into the nuances of pediatric gastrointestinal imaging techniques, focusing on three specific modalities: gastric emptying scintigraphy (GES), intestinal transit scintigraphy (ITS), and gastrointestinal bleeding scintigraphy. GES involves real-time monitoring of stomach emptying using radiotracers and gamma camera technology. While challenges exist in standardizing protocols due t...
Source: Quarterly Journal of Nuclear Medicine and Molecular Imaging - April 8, 2024 Category: Nuclear Medicine Authors: Maria C Garganese Milena Pizzoferro Source Type: research

Update on FDG-PET in pediatric lymphoma
Q J Nucl Med Mol Imaging. 2024 Mar;68(1):58-69. doi: 10.23736/S1824-4785.24.03560-X.ABSTRACTLymphoma represent the third most common malignant disease in childhood and adolescence. They are divided into pediatric Hodgkin lymphoma (P-HL) and pediatric non-Hodgkin lymphoma (P-NHL). In P-HL, excellent cure rates are achieved through combined modality treatment using chemotherapy and radiotherapy. For more than 20 years, FDG-PET has been an integral part of the treatment and guides its intensity through improved staging and precise assessment of chemotherapy response. In P-NHL, good cure rates are achieved with chemotherapy al...
Source: Quarterly Journal of Nuclear Medicine and Molecular Imaging - April 8, 2024 Category: Nuclear Medicine Authors: Lars Kurch Regine Kluge Source Type: research